A Study to Assess the Safety and Efficacy of Etrasimod in Subjects With Moderate-to-Severe Atopic Dermatitis
Completed · Phase 2 · Has a placebo group
Conditions studied: Atopic Dermatitis
In brief
The purpose of this study is to determine whether etrasimod is a safe and effective treatment for moderate-to-severe atopic dermatitis (AD).
Key facts
- Study ID
- NCT04162769
- Run by
- Arena Pharmaceuticals
- People needed
- 140
- Starts
- 2019-10-04
- Expected to finish
- 2021-10-11
- Last updated by the study team
- 2022-11-04
Who can join
Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Participants with chronic atopic dermatitis, defined by Hanifin and Rajka criteria, that has been present for at least 1 year prior to the Screening Visit
- Participants with Eczema Area and Severity Index (EASI) ≥ 12 at the Screening Visit and ≥ 16 at the Baseline Visit
- Participants with validated Investigator's Global Assessment (vIGA) score ≥ 3 (on the 0 to 4 vIGA scale, in which 3 = moderate and 4 = severe) involvement at the Screening and Baseline visits
You may not qualify if…
- Presence of skin comorbidities that would interfere with study assessments of the underlying disease.
Where it is running
- Noble Clinical Research — Tucson, Arizona, United States
- Hope Clinical Research — Canoga Park, California, United States
- First OC Dermatology — Fountain Valley, California, United States
- Marvel Research LLC — Huntington Beach, California, United States
- ADVA Clinical Research, Inc — Inglewood, California, United States
- Providence Clinical Research — North Hollywood, California, United States
- TCR Medical Corporation — San Diego, California, United States
- Clinical Research of West Florida — Clearwater, Florida, United States
- Prohealth Research Center — Doral, Florida, United States
- Aby's New Generation Research, Inc. — Hialeah, Florida, United States
- Skin Care Research, LLC — Hollywood, Florida, United States
- Advanced Research Institute of Miami LLC — Homestead, Florida, United States
- Amber Pediatrics Research, LLC — Homestead, Florida, United States
- South Miami Medical & Research Group. Inc — Miami, Florida, United States
- Amber Pediatrics Research, LLC — Miami, Florida, United States
- Skin Research of South Florida — Miami, Florida, United States
- Amber Clinical Research, LLC — Miami Shores, Florida, United States
- IMA Clinical Research, LLC — St. Petersburg, Florida, United States
- Clinical Research of West Florida, Inc. — Tampa, Florida, United States
- Rophe Adult and Pediatric Medicine/SKYCRNG — Union City, Georgia, United States
- Skin Sciences PLLC — Louisville, Kentucky, United States
- Quinn Healthcare/SKYCRNG — Ridgeland, Mississippi, United States
- Quality Clinical Research Inc — Omaha, Nebraska, United States
- Excel Clinical Research — Las Vegas, Nevada, United States
- Greenwich Village Dermatology — New York, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.